The effect of new drug pricing systems and new reimbursement guidelines on pharmaceutical expenditures and prescribing behavior among hypertensive patients in Korea

Mee-Hyun Cho, Ki-Bong Yoo, Hoo-Yeon Lee, Kwang-Sig Lee, Jeoung A Kwon, Kyu-Tae Han, Jae-Hyun Kim and Eun-Cheol Park

Health Policy, 2015, vol. 119, issue 5, 604-611

Abstract: The purpose of this study was to determine the effects of a new drug-pricing system (January 2012) and new prescription and reimbursement guidelines (January 2013) on hypertension-related pharmaceutical expenditures and prescribing behaviors in Korea.

Keywords: Pharmaceutical expenditures; Pharmaceutical policy; Drug pricing system; Antihypertensive drugs (search for similar items in EconPapers)
Date: 2015
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851015000056
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:119:y:2015:i:5:p:604-611

DOI: 10.1016/j.healthpol.2015.01.002

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().